SYSMEX Corp/ADR (SSMXY) Issues FY 2018 Earnings Guidance

SYSMEX Corp/ADR (OTCMKTS:SSMXY) issued an update on its FY 2018 earnings guidance on Wednesday morning. The company provided EPS guidance of $1.67-1.67 for the period. The company issued revenue guidance of $2.64-2.64 billion.

Shares of SSMXY opened at $29.14 on Friday. The firm has a market cap of $14.56 billion, a price-to-earnings ratio of 43.67 and a beta of 0.55. SYSMEX Corp/ADR has a 12 month low of $29.07 and a 12 month high of $50.46.

Separately, ValuEngine cut shares of SYSMEX Corp/ADR from a buy rating to a hold rating in a research report on Wednesday.

COPYRIGHT VIOLATION NOTICE: “SYSMEX Corp/ADR (SSMXY) Issues FY 2018 Earnings Guidance” was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & copyright legislation. The legal version of this news story can be viewed at https://sportsperspectives.com/2018/11/09/sysmex-corp-adr-ssmxy-issues-fy-2018-earnings-guidance.html.

About SYSMEX Corp/ADR

Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals.

Further Reading: Hedge Funds Explained

Receive News & Ratings for SYSMEX Corp/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SYSMEX Corp/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply